LQDA

NEUTRALEarnings

Liquidia Corporation

2026-06-26

Price

$78.17

+1.63%

This is the 2026-06-26 snapshot — the signals and analysis for LQDA as of this single trading day.

View full LQDA research hub →

Score2.2Noise

Signals4/8 DNA0/13 Act · 2/4 Risk

SentimentNEUTRALScore: 8

Volume1.3xvs 20d avg

Analysis

Liquidia (LQDA) is undergoing High-Conviction Price Discovery driven by the explosive commercial success of its YUTREPIA launch and a massive Q1 earnings beat. With PERFECT_STACK and SURGE signals firing, the stock's +30.4% relative strength perfectly illustrates a rotation out of the tech-heavy CAUTION macro regime into profitable, high-growth biotechs. Furthermore, the market's ability to effortlessly absorb a recent $7.5M insider sale points to robust Institutional Absorption ahead of its pending S&P SmallCap 600 inclusion.

Fired Signals

SURGEALPHA MALEGOLDEN CROSSPERFECT STACKWEAK FINISHEXTENSION

Key Takeaways

Actionable Thesis: Capitalize on the strong PERFECT_STACK and ALPHA_MALE signals as institutional rotation favors profitable biotechs with accelerating revenue.
Key Risk: Heavy insider selling and lingering legal overhangs from the '327 bench trial could introduce sudden volatility.
What to Watch: Price action around the recent highs; sustained volume above the 1.3x average indicates continued institutional accumulation.

← Back to 2026-06-26 View Full LQDA History →Yahoo Finance &nearr;